AHLWEST vs CELLPOINT: Stock Comparison
AHLWEST is the larger company by market capitalisation. AHLWEST shows a higher net margin, while CELLPOINT shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AHLWEST leads 3; CELLPOINT leads 3 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | AHLWEST | CELLPOINT |
|---|---|---|
| Live Price | ₹269.95 | — |
| Day Change | 10% | — |
| Volume | 11,019 | — |
| 52-Week High | ₹269.95 | — |
| 52-Week Low | ₹166.51 | — |
| Distance from 52W High | 0% | — |
Valuation
| Metric | AHLWEST | CELLPOINT |
|---|---|---|
| Market Cap | ₹650 Cr | ₹27 Cr |
| P/E Ratio | 11.26x | — |
| P/B Ratio | -47.7x | — |
| EPS | ₹12.26 | ₹0.03 |
| Book Value | — | ₹39.77 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | AHLWEST | CELLPOINT |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | — | 107.94% |
| Qtr Profit Growth | 7,742% | -66.67% |
Profitability & Leverage
| Metric | AHLWEST | CELLPOINT |
|---|---|---|
| ROE | -8.51% | 0.09% |
| ROCE | -1.49% | 0.34% |
| Net Margin | 14.92% | 0% |
| Operating Margin | — | 2.01% |
| Debt to Equity | 3.95x | 1.04x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | AHLWEST | CELLPOINT |
|---|---|---|
| Promoter Holding | 25.9% | 73.06% |
| FII Holding | 0% | 0% |
| DII Holding | 0.57% | 0% |
| Public Holding | 27.31% | 26.94% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AHLWEST and CELLPOINT.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.